Get started
Author

Steven F. L. van Lelyveld

Observed names: S F L van Lelyveld, S. F. L. Lelyveld, S. F. L. van Lelyveld, S. F.L. van Lelyveld, S.F.L. van Lelyveld, S. F. L. van Lelyveld, STEVEN LELYVELD, Steven FL van Lelyveld, Steven F L Van Lelyveld, Steven F L van Lelyveld, Steven F.L. Van Lelyveld, Steven F.L. van Lelyveld, Steven F. L. van Lelyveld, Steven FL van Lelyveld, Steven Ferdinand Lodewijk van Lelyveld
Observed institutions: University Medical Center Groningen, Centre for Human Genetics, University of Groningen, Utrecht University, University Medical Center Utrecht, University of Oxford, Reinier de Graaf Hospital, Spaarne Ziekenhuis, Spaarne Gasthuis
ORCID: 0000-0001-9153-8196
Observed ORCID: 0000-0001-9153-8196
OpenAlex ID: A5049826686
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
2011 · Steven F.L. van Lelyveld, Luuk Gras, et al. · AIDS · 114
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study
2020 · Colette Smit, Anders Boyd, et al. · The Lancet HIV · 72
PDF
A highly virulent variant of HIV-1 circulating in the Netherlands
2022 · Chris Wymant, Daniela Bezemer, et al. · Science · 71
High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands
2017 · Anne Boerekamps, Astrid M Newsum, et al. · Clinical Infectious Diseases · 67
PDF
Global spatiotemporal dynamics of Mycoplasma pneumoniae re-emergence after COVID-19 pandemic restrictions: an epidemiological and transmission modelling study
2025 · Patrick M Meyer Sauteur, Xu-Sheng Zhang, et al. · The Lancet Microbe · 58
Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis
2024 · Berend J van Welzen, Steven F L Van Lelyveld, et al. · Clinical Infectious Diseases · 57
PDF
Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023
2024 · Dita C Bolluyt, Sjoerd M Euser, et al. · Eurosurveillance · 53
PDF
The role of antibody-dependent enhancement in dengue vaccination
2024 · D. G. Aynekulu Mersha, I. van der Sterren, et al. · Tropical Diseases Travel Medicine and Vaccines · 43
PDF
Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit
2011 · S. F. L. Lelyveld, C. M. Wind, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 37
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial
2015 · Steven F. L. van Lelyveld, Julia Drylewicz, et al. · PLoS ONE · 34
PDF
Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
2024 · Erich Tusch, Lene Ryom, et al. · Clinical Infectious Diseases · 31
Quantification of naive and memory T-cell turnover during HIV-1 infection
2015 · Nienke Vrisekoop, Julia Drylewicz, et al. · AIDS · 31
Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice
2011 · J. Symons, L. Vandekerckhove, et al. · Clinical Microbiology and Infection · 30
PDF
Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient
2011 · J. Symons, S. F. L. van Lelyveld, et al. · Journal of Antimicrobial Chemotherapy · 30
Therapy Failure following Selection of Enfuvirtide‐Resistant HIV‐1 in Cerebrospinal Fluid
2010 · S. F. L. van Lelyveld, M. Nijhuis, et al. · Clinical Infectious Diseases · 29
High Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission Rates Detected by Dense Saliva Sampling
2022 · Lisa M Kolodziej, Steven F L van Lelyveld, et al. · Clinical Infectious Diseases · 23
PDF
The role of T cells in the development of cardiovascular disease in HIV-infected patients
2014 · M. Krikke, S.F.L. van Lelyveld, et al. · Atherosclerosis · 21
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
2023 · Bernard Surial, Adrià Ramírez Mena, et al. · Journal of Hepatology · 17
PDF
Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?
2013 · Annelot F. Schoffelen, Steven F.L. van Lelyveld, et al. · AIDS · 16
PDF
Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity
2010 · A. Fun, K. Van Baelen, et al. · Journal of Antimicrobial Chemotherapy · 15
Post COVID-19 Pandemic Increased Detection of Mycoplasma Pneumoniae in Adults Admitted to the Intensive Care
2024 · M. Goeijenbier, S. van der Bie, et al. · Journal of Clinical Medicine · 11
QTc Prolongation in COVID-19 Patients Using Chloroquine
2021 · Matthijs L. Becker, Dominic Snijders, et al. · Cardiovascular Toxicology · 11
PDF
Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy
2015 · Ananja Middel, Joop E. Arends, et al. · Neurology · 11
Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint
2013 · Rachel A. McGovern, Jori Symons, et al. · Journal of Antimicrobial Chemotherapy · 10
Lower Levels of Household Transmission of SARS-CoV-2 Omicron Variant of Concern vs Wild Type: An Interplay Between Transmissibility and Immune Status
2024 · Angelique M A M Winkel, Eva Kozanli, et al. · The Journal of Infectious Diseases · 9
PDF
Works count: 64
Citation count: 971
H-index: 17
I10-index: 24
Year
Topic
Type